問題 › AIが業界を変えています › プロフェッショナルサービス
問題はAIに何ができるかではありません。顧客や競合が自ら staffed しやすくなる自社の案件はどれかです。 専門サービス企業にとってこれを難しくしているのは構造的な要因です。パートナー報酬は合理的に、人々に最高マージンの製品を<em>not</em>売るよう支払います。したがって現実的な答えは、billable utilisation と realisation を同時に把握する必要があります。内部分析がここで止まるのは、この二つが別システムにあるためです。
問題はAIに何ができるかではありません。顧客や競合が自ら staffed しやすくなる自社の案件はどれかです。 専門サービス企業にとってこれを難しくしているのは構造的な要因です。パートナー報酬は合理的に、人々に最高マージンの製品をnot売るよう支払います。したがって現実的な答えは、billable utilisation と realisation を同時に把握する必要があります。内部分析がここで止まるのは、この二つが別システムにあるためです。
AI戦略の議論は大抵、能力から始まりどこにも着きません。能力は結果を決める変数ではないからです。変数は、請求している業務が競合や顧客にとって劇的に安くなるかどうかです。
それは案件ごとに答えられます。各収益ラインについて、自動化される billable hours の割合、時間以外で価格を守る要素の大きさ、競合が realisation rate と engagement margin で同等に達する速度を問います。
通常、露呈するのは収益性の高いラインです。高マージン業務は情報業務だからです。対応は通常、ツールを速く採用することではなく、自動化で価値が高まる方向へ課金の対象を移すことです。さもなくばパートナー報酬は引き続き最高マージン製品を売らないよう人を動かします。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ Utilisation は維持されるが、同じ案件で realisation rate が低下する
✓ 顧客が同一成果物に同一 billable hours が必要か疑問を持つ
✓ 新興企業が同等案件を自社 engagement gross margin のごく一部で価格提示する
通常、事態を悪化させる対応です。 課金の対象を変えずにツールを採用することです。これにより billable utilisation と価格が同時に低下し、マージンは変わりません。
It is for you if you run or finance a professional services firm and the pressure is showing up as price, not as lost deals. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 専門サービス企業. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Re-align partner economics so the $85K diagnostic becomes the highest-compensated path to the $410K implementation.
The leak it closes. Partner-level incentive leakage that currently diverts 25% of diagnostic-eligible opportunities back to T&M work
The assumption it rests on. 15-of-22 partners approve compensation redesign within 60 days — the engine put the probability at 0.7.
| Investment required | $700K total over 36 months — $200K annual incentive pool × 3 years + $100K legal and change-management cost |
| Expected return | 3.4× cash-on-cash over 36 months (NPV $2.4M / $700K investment) on $58.0M current revenue base |
| Revenue, year 1 | +$1.2M incremental diagnostic and implementation revenue (15 additional diagnostics × $85K + 12 conversions × $410K) |
| Revenue, year 2 | +$2.4M cumulative incremental revenue |
| Revenue, year 3 | +$3.7M cumulative incremental revenue |
| Exit criteria | Terminate this move and revert to legacy compensation if (a) fewer than 12-of-22 partners approve redesign by Day 60, or (b) any top-3 account issues an RFP within 90 days of announcement, or (c) diagnostic-to-implementation conversion falls below 10-of-19 by December 31, 2026. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to AI Horizon, one of 29 engagements the platform runs. For 専門サービス企業 it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
通常は内部が正しいです。自社の経済性を先に実証できるためです。例外は競合がすでに顧客期待値を変えた場合で、そのときは内部効率化では遅すぎます。
発表ではなく価格で判断してください。販売する成果物の市場価格が下がり始めたとき、技術が何を示そうと混乱はすでに到来しています。
小規模企業は通常、課金の対象を速く変えられる利点があります。重要なのは再配置であり、大規模既存企業より費用が低く済みます。
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית